(Q40444515)

20 September 2017

1 reference

title

Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system (English)

1 reference

20 September 2017

0 references

Lambert PD

1

1 reference

20 September 2017

Gross R

series ordinal

2

1 reference

20 September 2017

Nemeroff CB

series ordinal

3

1 reference

20 September 2017

Kilts CD

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Annals of the New York Academy of Sciences

20 September 2017

1 reference

20 September 2017

757

1 reference

20 September 2017

377-389

1 reference

Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin receptors are located on dopamine-containing neurones in rat midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Haloperidol-induced plasticity of axon terminals in rat substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin: central nervous system effects of a hypothalamic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

The effects of kininase II inhibition by SQ 14225 on kidney kallikrein-kinin and prostaglandin systems in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

The effect of neurotensin on food consumption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin depolarizes substantia nigra dopamine neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

The neurotensin analog xenopsin excites nigral dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Primary explants as a model of the hypothalamus in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Structure-activity studies with carboxy- and amino-terminal fragments of neurotensin on hypothalamic neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin excites neurons in the arcuate nucleus of the rat hypothalamus in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Effects of acute and chronic neuroleptic treatment on the activity of midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Structure and functional expression of the cloned rat neurotensin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Model systems for the study of seven-transmembrane-segment receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

The ontogeny of brain neurotensin receptors studied by autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Different postnatal development of cells expressing mRNA encoding neurotensin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Rapid agonist-induced decrease of neurotensin receptors from the cell surface in rat cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Binding and internalization of iodinated neurotensin in neuronal cultures from embryonic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Marked variations of the relative distributions of neurotensin and neuromedin N in micropunched rat brain areas suggest differential processing of their common precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E115 cells: implication of GTP-binding proteins and relationship with the cyclic GMP response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Modulation of dopamine D1 receptor binding by neurotensin in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Reduced CSF neurotensin concentration in drug-free schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

Neurotensin blocks certain amphetamine-induced behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB17496.X

10.1111/J.1749-6632.1995.TB17496.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference